These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [A new antihypertensive agent used in a clinical setting]. Wetzels E, Raschig A, Kaiser HJ. Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207 [Abstract] [Full Text] [Related]
8. Effects of clonidine and guanfacine in essential hypertension. Farsang C, Varga K, Vajda L, Alföldi S, Kapocsi J. Clin Pharmacol Ther; 1984 Nov 12; 36(5):588-94. PubMed ID: 6386275 [Abstract] [Full Text] [Related]
9. Comparative study of two antihypertensive agents: guanfacine and guanethidine. Szám I, Kállay K. Br J Clin Pharmacol; 1980 Nov 12; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786 [Abstract] [Full Text] [Related]
10. Effects of abrupt cessation of treatment with clonidine and guanfacine on blood pressure and heart rate in spontaneously hypertensive rats. Koike Y, Togashi H, Shimamura K, Yomaida I, Saito H. Clin Exp Hypertens (1978); 1981 Nov 12; 3(1):103-20. PubMed ID: 7009101 [Abstract] [Full Text] [Related]
11. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine. Jerie P. Br J Clin Pharmacol; 1980 Nov 12; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770 [Abstract] [Full Text] [Related]
12. Effects of clonidine and guanfacine on haemodynamics in hypertension. Sambhi MP. S Afr Med J; 1985 Oct 12; 68(8):552-4. PubMed ID: 3901325 [No Abstract] [Full Text] [Related]
13. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension. Bune AJ, Chalmers JP, Graham JR, Howe PR, West MJ, Wing LM. Eur J Clin Pharmacol; 1981 Oct 12; 19(5):309-15. PubMed ID: 7016550 [No Abstract] [Full Text] [Related]
14. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Sorkin EM, Heel RC. Drugs; 1986 Apr 12; 31(4):301-36. PubMed ID: 3519177 [Abstract] [Full Text] [Related]
15. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat. Thoolen MJ, Hendriks JC, Timmermans PB, van Zwieten PA. J Cardiovasc Pharmacol; 1983 Apr 12; 5(2):224-8. PubMed ID: 6188894 [Abstract] [Full Text] [Related]
16. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL, Strocchi E, Ambrosioni E, Magnani B. Int J Clin Pharmacol Res; 1983 Apr 12; 3(1):35-9. PubMed ID: 6384071 [Abstract] [Full Text] [Related]
17. Long-term antihypertensive therapy with guanfacine. Szám I, Holló J. Int J Clin Pharmacol Ther Toxicol; 1982 Aug 12; 20(8):388-92. PubMed ID: 6749702 [Abstract] [Full Text] [Related]
18. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine. Kirch W, Distler A. Int J Clin Pharmacol Biopharm; 1978 Mar 12; 16(3):132-5. PubMed ID: 348614 [Abstract] [Full Text] [Related]
19. Guanfacine as monotherapy for systemic hypertension. Fillingim JM, Blackshear JL, Strauss A, Strauss M. Am J Cardiol; 1986 Mar 28; 57(9):50E-54E. PubMed ID: 3513531 [Abstract] [Full Text] [Related]
20. Effect of guanfacine, an alpha-adrenergic agonist, on menopausal flushing. Tulandi T, Kinch RA, Lal S. Maturitas; 1986 Oct 28; 8(3):197-200. PubMed ID: 3537635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]